FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
pT4: Tumor invades adjacent structures (stomach) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades any of the following: main portal vein or its branches bilaterally, common hepatic artery, or other adjacent structures, such as the colon, stomach, duodenum, or abdominal wall (extrahepatic bile ducts) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall (urinary bladder) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades beyond Gerota's fascia (kidney) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades main portal vein or hepatic artery or invades two or more extrahepatic organs or structures (gallbladder) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures (ampulla of Vater) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion (testis) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor involves the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) with extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor of any size invades adjacent organ(s), e.g., vagina, urethra, bladder (anal canal) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor of any size with direct extension to chest wall or skin (breast) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor of lung as per AJCC 6th Edition definition (lung) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (small intestine) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor with extraocular extension (iris) (uveal melanoma) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor with intracranial extension, and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space (nasopharynx) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum (liver, including intrahepatic bile ducts) (finding) American Joint Committee on Cancer pT4 (qualifier value)
pT4a category (finding) pT4a
pT4a: Intrathyroidal anaplastic carcinoma - surgically resectable (anaplastic carcinoma) (thyroid) (finding) pT4a
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration (melanoma of the skin) (finding) pT4a
pT4a: Tumor directly invades other organs or structures (colon/rectum) (finding) pT4a
pT4a: Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses (maxillary sinus) (finding) pT4a
pT4a: Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses (nasal cavity and ethmoid sinus) (finding) pT4a
pT4a: Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, subglottis) (finding) pT4a
pT4a: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) not more than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) pT4a
pT4a: Tumor invades prostate or uterus or vagina (urinary bladder) (finding) pT4a
pT4a: Tumor invades skin, mandible, ear canal, and/or facial nerve (major salivary glands) (finding) pT4a
pT4a: Tumor invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid muscle, hard palate, or mandible (oropharynx) (finding) pT4a
pT4a: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose (lip) (finding) pT4a
pT4a: Tumor invades through cortical bone, into deep (extrinsic) muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face (oral cavity) (finding) pT4a
pT4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, supraglottis) (finding) pT4a
pT4a: Tumor invades through thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep intrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, glottis) (finding) pT4a
pT4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus or central compartment of soft tissue (hypopharynx) (finding) pT4a
pT4a: Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve (thyroid) (finding) pT4a
pT4a: Tumor of any size with extension to chest wall, not including pectoralis muscle (breast) pT4a
pT4a: Tumor penetrates to surface of visceral peritoneum (colon/rectum) (finding) pT4a
pT4b category (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Extrathyroidal anaplastic carcinoma - surgically unresectable (anaplastic carcinoma) (thyroid) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration (melanoma of the skin) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor directly invades or is adherent to other organs or structures (colon/rectum) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (maxillary sinus) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (nasal cavity and ethmoid sinus) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) greater than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery (oropharynx) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases internal carotid artery (oropharynx) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades pelvic wall or abdominal wall (urinary bladder) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels (thyroid) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures (hypopharynx) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, glottis) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, subglottis) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, supraglottis) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor invades skull base and/or pterygoid plates and/or encases carotid artery (major salivary glands) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor involves masticator space, pterygoid plates, or skull base and/or encases internal carotid artery (lip and oral cavity) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor involves masticator space, pterygoid plates, or skull base and/or encases internal carotid artery (oropharynx) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor of any size with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast American Joint Committee on Cancer pT4b (qualifier value)
pT4b: Tumor penetrates visceral peritoneum (colon/rectum) (finding) American Joint Committee on Cancer pT4b (qualifier value)
pT4c category (finding) pT4c
pT4c: Tumor of any size with direct extension to chest wall (not including pectoralis muscle) and edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast pT4c
pT4d category (finding) American Joint Committee on Cancer pT4d (qualifier value)
pT4d: Inflammatory carcinoma (breast) American Joint Committee on Cancer pT4d (qualifier value)
pTX category (finding) pTX
pTX: Primary tumor cannot be assessed (breast) pTX
pTX: Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy (lung) (finding) pTX
pTa: Non-invasive papillary carcinoma (urinary bladder, ureter, renal pelvis) (finding) pTa
pTis category (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Carcinoma in situ (breast) American Joint Committee on Cancer pTis (qualifier value)
pTis: Carcinoma in situ (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Carcinoma in situ, intraepithelial (appendix) (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Carcinoma in situ, intraepithelial (colon/rectum) (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Carcinoma in situ, invasion of lamina propria (appendix) (finding) pTis(LAMN)
pTis: Carcinoma in situ, invasion of lamina propria (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Ductal carcinoma in situ (breast) American Joint Committee on Cancer pTis(DCIS) (qualifier value)
pTis: Flat carcinoma in situ (urinary bladder, ureter, renal pelvis) (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Intratubular germ cell neoplasia (carcinoma in situ) (testis) (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Lobular carcinoma in situ (breast) American Joint Committee on Cancer pTis (qualifier value)
pTis: Melanoma in situ (melanoma of the skin) (finding) American Joint Committee on Cancer pTis (qualifier value)
pTis: Paget disease without invasive carcinoma (breast) (finding) pTis(Paget)
pTis: Tumor invades muscularis mucosae (colon/rectum) American Joint Committee on Cancer pTis (qualifier value)
Diagnostic palpation (procedure) palpation
Pamidronate disodium 3mg/mL infusion concentrate 5mL vial (product) Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug)
para-aminohippuric acid (substance) acide para-aminohippurique
No known allergies pas d'allergie connue
Patient died at home Died at home
Piperacillin 1g powder for injection solution vial (product) Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Piperacillin 2g powder for injection solution vial (product) Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial
Piperacillin 4g powder for injection solution vial (product) Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial
Piperacillin 4g/tazobactam 500mg powder and solvent for infusion vial (product) pipéracilline 4 g/tazobactam 500 mg, fiole de poudre pour solution injectable (médicament clinique)
Learning disabilities health action plan completed (procedure) Completion of learning disabilities health action plan (procedure)
Radiotherapy planning using magnetic resonance imaging Magnetic resonance imaging for radiotherapy planning
Conventional release vapor ointment for inhalation (dose form) Ointment for vapour inhalation
Hepatitis B immunoglobulin 1000iu powder for injection solution vial (product) Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form
poudre de 125 UI d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon Varicella-zoster virus antibody 104 unit/mL solution for injection
Hepatitis B immunoglobulin 200iu powder for injection solution vial (product) Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form
Hepatitis B immunoglobulin 500iu powder for injection solution vial (product) Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form
poudre pour inhalation par vapeur Conventional release powder for vapor inhalation (dose form)
poudre pour solution pour instillation endotrachéobronchique Powder for solution for endotracheopulmonary instillation
Gunpowder Gunpowder (substance)
Therapeutic prescription (situation) Prescription given (situation)
Product containing gluconolactone (medicinal product) Gluconic acid-containing product
Product containing gadoterate meglumine (medicinal product) Gadoteric acid-containing product

Start Previous Page 130 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start